Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-09

Clinical Trial Update: Fractional CO2 Laser-assisted Cutaneous Delivery of Methotrexate Versus 5-fluorouracil in Stable Non-segmental Vitiligo [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing fractional CO2 laser-assisted cutaneous delivery of methotrexate versus 5-fluorouracil for stable non-segmental vitiligo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Assiut University | Conditions: Vitiligo | Phase 4 | Status: UNKNOWN